Prospective randomized study of hyperthermia combined with chemoradiotherapy for esophageal carcinoma

Kaoru Kitamura, Hiroyuki Kuwano, Masayuki Watanabe, Tadahiro Nozoe, Mitsuhiro Yasuda, Kohei Sumiyoshi, Motonori Saku, Keizo Sugimachi

Research output: Contribution to journalArticle

78 Citations (Scopus)

Abstract

From January 1988 to June 1992, 66 patients with resectable squamous cell carcinoma of the thoracic esophagus underwent preoperative adjuvant therapy. These patients were prospectively divided into two treatment groups; 32 were treated with radiofrequency wave local hyperthermia combined with chemoradiotherapy (hyperthermochemoradiotherapy; HCR), while the remaining 34 patients were treated with chemoradiotherapy alone (CR). There were no procedural complications in either group and the postoperative mortality was zero. In the HCR group, no viable cancer cells were found within the entire 5 mm‐width slices of the resected specimen in eight patients (25%), while only two (5.9%) in the CR group (P < 0.05) demonstrated no viable cancer cells. The cumulative 3‐year survival rate was 50.4% in the HCR group and 24.2% in the CR group. The present prospective trial demonstrated that the addition of hyperthermia to chemoradiotherapy resulted in a better local control and an improved long‐term survival when treating patients with advanced esophageal carcinoma. © 1995 Wiley‐Liss, Inc.

Original languageEnglish
Pages (from-to)55-58
Number of pages4
JournalJournal of Surgical Oncology
Volume60
Issue number1
DOIs
Publication statusPublished - Sep 1995

Fingerprint

Chemoradiotherapy
Fever
Prospective Studies
Carcinoma
Induced Hyperthermia
Esophagus
Squamous Cell Carcinoma
Neoplasms
Thorax
Survival Rate
Survival
Mortality
Therapeutics

All Science Journal Classification (ASJC) codes

  • Surgery
  • Oncology

Cite this

Kitamura, K., Kuwano, H., Watanabe, M., Nozoe, T., Yasuda, M., Sumiyoshi, K., ... Sugimachi, K. (1995). Prospective randomized study of hyperthermia combined with chemoradiotherapy for esophageal carcinoma. Journal of Surgical Oncology, 60(1), 55-58. https://doi.org/10.1002/jso.2930600111

Prospective randomized study of hyperthermia combined with chemoradiotherapy for esophageal carcinoma. / Kitamura, Kaoru; Kuwano, Hiroyuki; Watanabe, Masayuki; Nozoe, Tadahiro; Yasuda, Mitsuhiro; Sumiyoshi, Kohei; Saku, Motonori; Sugimachi, Keizo.

In: Journal of Surgical Oncology, Vol. 60, No. 1, 09.1995, p. 55-58.

Research output: Contribution to journalArticle

Kitamura, K, Kuwano, H, Watanabe, M, Nozoe, T, Yasuda, M, Sumiyoshi, K, Saku, M & Sugimachi, K 1995, 'Prospective randomized study of hyperthermia combined with chemoradiotherapy for esophageal carcinoma', Journal of Surgical Oncology, vol. 60, no. 1, pp. 55-58. https://doi.org/10.1002/jso.2930600111
Kitamura, Kaoru ; Kuwano, Hiroyuki ; Watanabe, Masayuki ; Nozoe, Tadahiro ; Yasuda, Mitsuhiro ; Sumiyoshi, Kohei ; Saku, Motonori ; Sugimachi, Keizo. / Prospective randomized study of hyperthermia combined with chemoradiotherapy for esophageal carcinoma. In: Journal of Surgical Oncology. 1995 ; Vol. 60, No. 1. pp. 55-58.
@article{34670959e34c43058172b126d3b8f49e,
title = "Prospective randomized study of hyperthermia combined with chemoradiotherapy for esophageal carcinoma",
abstract = "From January 1988 to June 1992, 66 patients with resectable squamous cell carcinoma of the thoracic esophagus underwent preoperative adjuvant therapy. These patients were prospectively divided into two treatment groups; 32 were treated with radiofrequency wave local hyperthermia combined with chemoradiotherapy (hyperthermochemoradiotherapy; HCR), while the remaining 34 patients were treated with chemoradiotherapy alone (CR). There were no procedural complications in either group and the postoperative mortality was zero. In the HCR group, no viable cancer cells were found within the entire 5 mm‐width slices of the resected specimen in eight patients (25{\%}), while only two (5.9{\%}) in the CR group (P < 0.05) demonstrated no viable cancer cells. The cumulative 3‐year survival rate was 50.4{\%} in the HCR group and 24.2{\%} in the CR group. The present prospective trial demonstrated that the addition of hyperthermia to chemoradiotherapy resulted in a better local control and an improved long‐term survival when treating patients with advanced esophageal carcinoma. {\circledC} 1995 Wiley‐Liss, Inc.",
author = "Kaoru Kitamura and Hiroyuki Kuwano and Masayuki Watanabe and Tadahiro Nozoe and Mitsuhiro Yasuda and Kohei Sumiyoshi and Motonori Saku and Keizo Sugimachi",
year = "1995",
month = "9",
doi = "10.1002/jso.2930600111",
language = "English",
volume = "60",
pages = "55--58",
journal = "Journal of Surgical Oncology",
issn = "0022-4790",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Prospective randomized study of hyperthermia combined with chemoradiotherapy for esophageal carcinoma

AU - Kitamura, Kaoru

AU - Kuwano, Hiroyuki

AU - Watanabe, Masayuki

AU - Nozoe, Tadahiro

AU - Yasuda, Mitsuhiro

AU - Sumiyoshi, Kohei

AU - Saku, Motonori

AU - Sugimachi, Keizo

PY - 1995/9

Y1 - 1995/9

N2 - From January 1988 to June 1992, 66 patients with resectable squamous cell carcinoma of the thoracic esophagus underwent preoperative adjuvant therapy. These patients were prospectively divided into two treatment groups; 32 were treated with radiofrequency wave local hyperthermia combined with chemoradiotherapy (hyperthermochemoradiotherapy; HCR), while the remaining 34 patients were treated with chemoradiotherapy alone (CR). There were no procedural complications in either group and the postoperative mortality was zero. In the HCR group, no viable cancer cells were found within the entire 5 mm‐width slices of the resected specimen in eight patients (25%), while only two (5.9%) in the CR group (P < 0.05) demonstrated no viable cancer cells. The cumulative 3‐year survival rate was 50.4% in the HCR group and 24.2% in the CR group. The present prospective trial demonstrated that the addition of hyperthermia to chemoradiotherapy resulted in a better local control and an improved long‐term survival when treating patients with advanced esophageal carcinoma. © 1995 Wiley‐Liss, Inc.

AB - From January 1988 to June 1992, 66 patients with resectable squamous cell carcinoma of the thoracic esophagus underwent preoperative adjuvant therapy. These patients were prospectively divided into two treatment groups; 32 were treated with radiofrequency wave local hyperthermia combined with chemoradiotherapy (hyperthermochemoradiotherapy; HCR), while the remaining 34 patients were treated with chemoradiotherapy alone (CR). There were no procedural complications in either group and the postoperative mortality was zero. In the HCR group, no viable cancer cells were found within the entire 5 mm‐width slices of the resected specimen in eight patients (25%), while only two (5.9%) in the CR group (P < 0.05) demonstrated no viable cancer cells. The cumulative 3‐year survival rate was 50.4% in the HCR group and 24.2% in the CR group. The present prospective trial demonstrated that the addition of hyperthermia to chemoradiotherapy resulted in a better local control and an improved long‐term survival when treating patients with advanced esophageal carcinoma. © 1995 Wiley‐Liss, Inc.

UR - http://www.scopus.com/inward/record.url?scp=0029162356&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029162356&partnerID=8YFLogxK

U2 - 10.1002/jso.2930600111

DO - 10.1002/jso.2930600111

M3 - Article

C2 - 7545257

AN - SCOPUS:0029162356

VL - 60

SP - 55

EP - 58

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

IS - 1

ER -